Coral Labs, a company in the Pharmaceuticals industry, reported revenue of ₹30 crore and net profit of ₹5.39 crore for the June 2026 quarter.
Coral Labs. (BSE: CORALAB) closed at ₹680.00 on 20 Nov 2026, up 35.3% over the past year. Its market capitalisation is ₹243 crore and it trades at 11.1 times earnings.
Incorporated in 1994, Coral Laboratories Ltd is in the business of pharmaceutical formulations
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.